UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 14)


	Onyx Pharmaceuticals, Inc.

	(Name of Issuer)

	Common Stock

	(Title of Class of Securities)

	683399109

	(CUSIP Number)

	September 10, 2007

	(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:

	[   ]Rule 13d-1(b)

	[ X ]Rule 13d-1(c)

	[   ]Rule 13d-1(d)



=============================================================================


CUSIP No. 683399109

-----------------------------------------------------------------------------

1.Names of Reporting Persons.

   	Meditor Group Ltd.


  I.R.S. Identification Nos. of above persons (entities only).

   	.................


2.Check the Appropriate Box if a Member of a Group (See Instructions)

	[   ](a)

	[   ](b)


3.SEC Use Only





4.Citizenship or Place of Organization

   	Bermuda


Number of Shares Beneficially Owned by Each Reporting Person With:

5.Sole Voting Power

   	.........


6.Shared Voting Power

   	2,627,800


7.Sole Dispositive Power

   	.........


8.Shared Dispositive Power

   	2,627,800


9.Aggregate Amount Beneficially Owned by Each Reporting Person

   	2,627,800


10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares


	[   ]


11.Percent of Class Represented by Amount in Row (9)

   	4.8%


12.Type of Reporting Person (See Instructions)

   	CO

=============================================================================


Item 1.

(a) Name of Issuer

	Onyx Pharmaceuticals, Inc.


(b) Address of Issuer's Principal Executive Offices

	2100 Powell Street, Emeryville, CA94608


Item 2.

(a) Name of Person Filing

   	Meditor Group Ltd.


(b) Address of Principal Business Office or, if none, Residence

   	79 Front Street, Hamilton, Bermuda


(c) Citizenship

   	Bermuda


(d) Title of Class of Securities

	Common Stock


(e) CUSIP Number

	683399109


Item 3.

	Not applicable.


Item 4. Ownership.

(a) Amount beneficially owned:

   	2,627,800


(b) Percent of class:

   	4.8%


(c) Number of shares as to which the person has:


(i) Sole power to vote or to direct the vote

   	.........


(ii) Shared power to vote or to direct the vote

   	2,627,800


(iii) Sole power to dispose or to direct the disposition of

   	.........


(iv) Shared power to dispose or to direct the disposition of

   	2,627,800


Item 5. Ownership of Five Percent or Less of a Class

	Not applicable.


Item 6. Ownership of More than Five Percent on Behalf of Another Person.

	Various persons, as investment management clients of
	Meditor Group Ltd., have the right to receive or the power
	to direct the receipt of dividends from, or the proceeds
	from the sale of, the securities disclosed herein.

	To the knowledge of Meditor Group Ltd., no one such person's interest
	in the common stock of the Issuer is more than 5.0%.


Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control Person.

	Not applicable.


Item 8. Identification and Classification of Members of the Group

	Not applicable.


Item 9. Notice of Dissolution of Group

	Not applicable.


Item 10. Certification

	By signing below the undersigned certifies that, to the best of its
	knowledge and belief, the securities referred to above were not
	acquired and are not held for the purpose of or with the effect of
	changing or influencing the control of the issuer of the securities
	and were not acquired and are not held in connection with or as a
	participant in any transaction having that purpose or effect.


SIGNATURE

	After reasonable inquiry and to the best of our knowledge and belief,
	we certify that the information set forth in this statement is true,
	complete and correct.


	September 12, 2007


	Meditor Group Ltd.

     By	S. Shakerchi (Director)